Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma

Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma

Abstract. The serum soluble CD163 (sCD163) is elevated in patients with inflammatory disease and several types of cancer. However, the prognostic value of serum sCD163 in pancreatic ductal adenocarcinoma (PDAC) has not yet been investigated. In this study, serum level of sCD163 was measured by using...

Full description

Bibliographic Details
Main Authors:	Qinglin Fei, MD, Yu Pan, MD, PhD, Xingxing Yu, MD, Ronggui Lin, MD, PhD, Xianchao Lin, MD, PhD, Heguagn Huang, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2020-09-01
Series:	Journal of Pancreatology
Online Access:	http://journals.lww.com/10.1097/JP9.0000000000000055

Similar Items

Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma
by: Boram Lee, MD, et al.
Published: (2021-09-01)

Pancreatic ductal adenocarcinoma: the role of circulating tumor DNA
by: Joseph R. Habib, MD, et al.
Published: (2019-09-01)

Long-Term Outcomes of Venous Resections in Pancreatic Ductal Adenocarcinoma Patients
by: Martin Sillesen, MD, PhD, et al.
Published: (2022-12-01)

Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis
by: Yingjian Ye MD, et al.
Published: (2023-06-01)

Preoperative Biliary Drainage Does Not Independently Reduce Survival After Pancreaticoduodenectomy Among Patients With Pancreatic Ductal Adenocarcinoma
by: Karin Johansen, MD, et al.
Published: (2021-09-01)

Liver metastases from pancreatic ductal adenocarcinoma: is there a place for surgery in the modern era?
by: Katsunori Imai, MD, PhD, FACS, et al.
Published: (2020-06-01)

Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
by: Yunyu Lian BM, et al.
Published: (2023-08-01)

Comment on “Perineural Invasion In Pancreatic Ductal Adenocarcinoma—What Can We Learn From The Past?’’
by: Xiaofei Shen, MD, PhD
Published: (2021-06-01)

Potential Impact of on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
by: Sung Hwan Lee MD, PhD, et al.
Published: (2019-02-01)

Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling
by: Shuo Wang PhD, et al.
Published: (2022-10-01)

Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis
by: Muttanagouda Giriyappagoudar MD, et al.
Published: (2023-07-01)

Comment on: “Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma”
by: Yangyang Zheng, MM, et al.
Published: (2023-03-01)

Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
by: Victor Hugo Fonseca de Jesus MD, MSc, et al.
Published: (2023-04-01)

Endoscopic treatment of large impacted pancreatic ductal stone using digital pancreatoscopy and electrohydraulic lithotripsy
by: Hitoshi Shibuya, MD, et al.
Published: (2018-03-01)

Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism
by: Shentao Li MBBS, et al.
Published: (2020-09-01)

EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report
by: Sho Takuma, MD, et al.
Published: (2022-01-01)

Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
by: Carl S. Leonhardt, MD, et al.
Published: (2020-03-01)

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
by: Liva K. Stuhr, et al.
Published: (2023-01-01)

Scorecards: Quantifying Dosimetric Plan Quality in Pancreatic Ductal Adenocarcinoma Stereotactic Body Radiation Therapy
by: Kareem Rayn, MD, et al.
Published: (2023-11-01)

Adjuvant and neoadjuvant therapy for pancreatic cancer
by: Shimpei Maeda, MD, PhD, et al.
Published: (2019-09-01)

The impact of sarcopenia on patients undergoing treatment for pancreatic ductal adenocarcinoma
by: Julia R. Amundson, MD, MPH, et al.
Published: (2020-06-01)

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors
by: Hideki Ikeda, MD, et al.
Published: (2023-10-01)

Successful EUS-guided nondilated pancreatic duct stent placement in patient with refractory pancreatic fistula after pancreaticoduodenectomy
by: Kazuhiro Minami, MD, et al.
Published: (2017-11-01)

A small adenocarcinoma in the cervical esophagus
by: Kyosuke Tanaka, MD, PhD, et al.
Published: (2019-03-01)

Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary Adenocarcinoma
by: Hironori Ninomiya, MD, PhD, et al.
Published: (2022-04-01)

Successful Laparoscopic Treatment of Pancreatic Metastasis From Sigmoid Colon Cancer: A Case Report
by: Masatsugu Ishii MD, PhD, et al.
Published: (2022-04-01)

Sudden aggravated CD8+ mycosis fungoides accompanied by hidden adenocarcinoma of the colon
by: Hye-Jin Ahn, MD, et al.
Published: (2017-03-01)

Radiomics in pancreatic ductal adenocarcinoma: a state of art review
by: Ming He, MD, et al.
Published: (2020-12-01)

PD-1 immunotherapy in pancreatic cancer: current status
by: Ning Pu, MD, et al.
Published: (2019-03-01)

Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy
by: Katsuhiro Yoshimura, MD, et al.
Published: (2017-01-01)

TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study
by: Yuki Katayama, MD, et al.
Published: (2023-04-01)

Hypercalcemia Owing to Overproduction of 1,25-Dihydroxyvitamin D3 in Fetal Lung Adenocarcinoma: Case Report
by: Tomohito Saito, MD, PhD, et al.
Published: (2021-08-01)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
by: Liping Zhuang MD, PhD, et al.
Published: (2020-11-01)

Serum C-Reactive Protein-to-Body Mass Index Ratio Predicts Overall Survival in Patients With Resected Colorectal Cancer
by: Lingxu Huang MD, et al.
Published: (2021-07-01)

Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressivenessCentral MessagePerspective
by: Takahiro Mimae, MD, PhD, et al.
Published: (2022-09-01)

Ceftriaxone-associated pancreatitis captured on serial computed tomography scans
by: Nozomu Nakagawa, MD, et al.
Published: (2018-02-01)

Pulmonary mucinous adenocarcinoma in the presence of reactivated tuberculosis: A case report
by: Serbeze Kabashi-Muçaj, MD, PhD, et al.
Published: (2021-12-01)

Tumor Atelectasis Gives Rise to a Solid Appearance in Pulmonary Adenocarcinomas on High-Resolution Computed Tomography
by: Francesca Ambrosi, MD, et al.
Published: (2020-06-01)

A Case Of Cystic Pheochromocytoma With Hypertension And Headaches Mimicking A Large Pancreatic Cystic Tumor
by: Satoshi Yamagata, MD, PhD, et al.
Published: (2017-01-01)

Preoperative Decision to Perform Portal Vein Resection Improves Survival in Patients With Resectable Pancreatic Head Cancer Adjacent to Portal Vein
by: Muga Terasawa, MD, et al.
Published: (2021-06-01)